


Madeira Therapeutics Revenue
Biotechnology Research • Leawood, Kansas, United States • 1-10 Employees
Madeira Therapeutics revenue & valuation
| Annual revenue | $9,374,387 |
| Revenue per employee | $9,375,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $30,000,000 |
| Total funding | $420,000 |
Key Contact at Madeira Therapeutics
Pete Joiner
CEO & President
Company overview
| Headquarters | 4745 W. 136th Street Suite #102, Leawood, KS 66224, US |
| Phone number | +19136611962 |
| Websites | |
| Keywords | Biotechnology, Pharmaceuticals, Drug Development, FDA, 505(B)(2), Pediatric, IND, Compound, Drug Development Company, Fda-Approved, Ind Approval, Pediatric Drug Medicines, Pediatric Pharmaceuticals, Reformulate Compounds, Reformulate Drug |
| Employees | 1-10 |
| Socials |
About Madeira Therapeutics
We are a drug development company specializing in real pediatric medicine by reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage. Currently, 70% of the drugs prescribed for children are not approved by the FDA. Children metabolize drugs more rapidly than adults; our goal is to eliminate the "dosing down" of adult drugs for children based on weight. Madeira Therapeutics is one of the few drug development companies with a dedicated focus on this niche market-formulations that are sized to fit.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Madeira Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



